Joop P Aendekerk1, Sjoerd A M E G Timmermans1, Matthias H Busch1, Judith Potjewijd1, Peter Heeringa2, Jan G M C Damoiseaux3, Chris P Reutelingsperger4, Pieter van Paassen5. 1. Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands. 2. Department of Medical Biology and Pathology, University Medical Center Groningen, Groningen, The Netherlands. 3. Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands. 4. Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands. 5. Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands p.vanpaassen@maastrichtuniversity.nl.
Abstract
BACKGROUND AND OBJECTIVES: ANCA-associated GN is a common cause of rapidly progressive GN, with high relapse rates. The early recognition of an ANCA-associated GN relapse is of importance to prevent loss of kidney function. Urinary soluble CD163 has been identified as a promising marker of active ANCA-associated GN. Previous studies, however, are limited by the lack of histologic data. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We analyzed urinary soluble CD163 in 95 patients with ANCA-associated vasculitis who underwent a kidney biopsy. In total, 125 kidney tissue sections (first kidney biopsy, n=67; repeated biopsy, n=58) with concurrent 24-hour urine samples were studied. Correlation analyses comparing urinary soluble CD163 levels and morphologic features of ANCA-associated GN were performed using Spearman rank correlation analysis. The diagnostic performance of biomarkers to detect relapsing ANCA-associated GN was evaluated using receiver operating characteristics curve analysis. RESULTS: High levels of urinary soluble CD163 were found in 96 (87%) of 110 biopsies with active ANCA-associated GN compared with one (7%) of 15 biopsies without active ANCA-associated GN and one (6%) of 17 healthy controls. Urinary soluble CD163 correlated with fibrinoid necrosis (Rho=0.48, P<0.001) and cellular crescents (Rho=0.70, P<0.001) on kidney biopsy. In repeated biopsies, urinary soluble CD163's sensitivity of 0.94 and specificity of 0.91 for the recognition of relapsing ANCA-associated GN appeared better than routine clinical measures. The presence of CD163+ cells in affected glomeruli confirmed urinary soluble CD163's origin. CONCLUSIONS: Urinary soluble CD163 is associated with active ANCA-associated GN and correlates with histologic features as seen in ANCA-associated GN. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_11_17_CJN07210520_final.mp3.
BACKGROUND AND OBJECTIVES: ANCA-associated GN is a common cause of rapidly progressive GN, with high relapse rates. The early recognition of an ANCA-associated GN relapse is of importance to prevent loss of kidney function. Urinary soluble CD163 has been identified as a promising marker of active ANCA-associated GN. Previous studies, however, are limited by the lack of histologic data. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We analyzed urinary soluble CD163 in 95 patients with ANCA-associated vasculitis who underwent a kidney biopsy. In total, 125 kidney tissue sections (first kidney biopsy, n=67; repeated biopsy, n=58) with concurrent 24-hour urine samples were studied. Correlation analyses comparing urinary soluble CD163 levels and morphologic features of ANCA-associated GN were performed using Spearman rank correlation analysis. The diagnostic performance of biomarkers to detect relapsing ANCA-associated GN was evaluated using receiver operating characteristics curve analysis. RESULTS: High levels of urinary soluble CD163 were found in 96 (87%) of 110 biopsies with active ANCA-associated GN compared with one (7%) of 15 biopsies without active ANCA-associated GN and one (6%) of 17 healthy controls. Urinary soluble CD163 correlated with fibrinoid necrosis (Rho=0.48, P<0.001) and cellular crescents (Rho=0.70, P<0.001) on kidney biopsy. In repeated biopsies, urinary soluble CD163's sensitivity of 0.94 and specificity of 0.91 for the recognition of relapsing ANCA-associated GN appeared better than routine clinical measures. The presence of CD163+ cells in affected glomeruli confirmed urinary soluble CD163's origin. CONCLUSIONS: Urinary soluble CD163 is associated with active ANCA-associated GN and correlates with histologic features as seen in ANCA-associated GN. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_11_17_CJN07210520_final.mp3.
Authors: Sanjeev Sethi; Vivette D D'Agati; Cynthia C Nast; Agnes B Fogo; An S De Vriese; Glen S Markowitz; Richard J Glassock; Fernando C Fervenza; Surya V Seshan; Andrew Rule; Lorraine C Racusen; Jai Radhakrishnan; Christopher G Winearls; Gerald B Appel; Ingeborg M Bajema; Anthony Chang; Robert B Colvin; H Terence Cook; Sundaram Hariharan; Loren P Herrera Hernandez; Neeraja Kambham; Michael Mengel; Karl A Nath; Helmut G Rennke; Pierre Ronco; Brad H Rovin; Mark Haas Journal: Kidney Int Date: 2017-04 Impact factor: 10.612
Authors: Pieter van Paassen; Peter J C van Breda Vriesman; Henk van Rie; Jan Willem Cohen Tervaert Journal: Kidney Int Date: 2004-09 Impact factor: 10.612
Authors: C Mukhtyar; R Lee; D Brown; D Carruthers; B Dasgupta; S Dubey; O Flossmann; C Hall; J Hollywood; D Jayne; R Jones; P Lanyon; A Muir; D Scott; L Young; R A Luqmani Journal: Ann Rheum Dis Date: 2008-12-03 Impact factor: 19.103
Authors: Rennie L Rhee; John C Davis; Linna Ding; Fernando C Fervenza; Gary S Hoffman; Cees G M Kallenberg; Carol A Langford; W Joseph McCune; Paul A Monach; Philip Seo; Robert Spiera; E William St Clair; Ulrich Specks; John H Stone; Peter A Merkel Journal: Clin J Am Soc Nephrol Date: 2018-01-25 Impact factor: 8.237
Authors: Marc Hilhorst; Benjamin Wilde; Peter van Breda Vriesman; Pieter van Paassen; Jan Willem Cohen Tervaert Journal: J Am Soc Nephrol Date: 2013-06-13 Impact factor: 10.121
Authors: Brad H Rovin; Dawn J Caster; Daniel C Cattran; Keisha L Gibson; Jonathan J Hogan; Marcus J Moeller; Dario Roccatello; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Jürgen Floege Journal: Kidney Int Date: 2019-02 Impact factor: 10.612
Authors: Sarah M Moran; Paul A Monach; Lina Zgaga; David Cuthbertson; Simon Carette; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Christian Pagnoux; Philip Seo; Ulrich Specks; Antoine Sreih; Jason Wyse; Steven R Ytterberg; Peter A Merkel; Mark A Little Journal: Nephrol Dial Transplant Date: 2020-02-01 Impact factor: 7.186
Authors: Adam D Morris; Camilo L M Morais; Kássio M G Lima; Daniel L D Freitas; Mark E Brady; Ajay P Dhaygude; Anthony W Rowbottom; Francis L Martin Journal: Sci Rep Date: 2021-05-11 Impact factor: 4.379
Authors: Adam D Morris; Daniel L D Freitas; Kássio M G Lima; Lauren Floyd; Mark E Brady; Ajay P Dhaygude; Anthony W Rowbottom; Francis L Martin Journal: Molecules Date: 2022-04-02 Impact factor: 4.411
Authors: Elena Cantero-Navarro; Sandra Rayego-Mateos; Macarena Orejudo; Lucía Tejedor-Santamaria; Antonio Tejera-Muñoz; Ana Belén Sanz; Laura Marquez-Exposito; Vanessa Marchant; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Teresa Bellon; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega Journal: Front Med (Lausanne) Date: 2021-07-08